Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2022

Open Access 01-03-2022 | Hepatocellular Carcinoma | Original Article

Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions

Authors: Kui Sun, Liting Shi, Jianfeng Qiu, Yuteng Pan, Ximing Wang, Haiyan Wang

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2022

Login to get access

Abstract

Purpose

This study aimed to investigate whether models built from radiomics features based on multiphase contrast-enhanced MRI can identify microscopic pre-hepatocellular carcinoma lesions.

Methods

We retrospectively studied 54 small hepatocellular carcinoma (SHCC, diameter < 2 cm) patients and 70 patients with hepatocellular cysts or haemangiomas from September 2018 to June 2021. For the former, two MRI scans were collected within 12 months of each other; the 2nd scan was used to confirm the diagnosis. The volumes of interest (VOIs), including SHCCs and normal liver tissues, were delineated on the 2nd scans, mapped to the 1st scans via image registration, and enrolled into the SHCC and internal-control cohorts, respectively, while those of normal liver tissues from patients with hepatocellular cysts or haemangioma were enrolled in the external-control cohort. We extracted 1132 radiomics features from each VOI and analysed their discriminability between the SHCC and internal-control cohorts for intra-group classification and the SHCC and external-control cohorts for inter-group classification. Five radial basis-function, kernel-based support vector machine (SVM) models (four corresponding single-phase models and one integrated from the four-phase MR images) were established.

Results

Among the 124 subjects, the multiphase models yielded better performance on the testing set for intra-group and inter-group classification, with areas under the receiver operating characteristic curves of 0.93 (95% CI, 0.85–1.00) and 0.97 (95% CI, 0.92–1.00), accuracies of 86.67% and 94.12%, sensitivities of 87.50% and 94.12%, and specificities of 85.71% and 94.12%, respectively.

Conclusion

The combined multiphase MRI-based radiomics feature model revealed microscopic pre-hepatocellular carcinoma lesions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild C, Weiderpass E, Stewart B. World cancer report cancer research for cancer prevention. International Agency for Research on Cancer; 2020. Wild C, Weiderpass E, Stewart B. World cancer report cancer research for cancer prevention. International Agency for Research on Cancer; 2020.
2.
go back to reference Yang T, Xing H, Wang G, et al. A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B. Clin Chem. 2019;65(12):1543–53.PubMedCrossRef Yang T, Xing H, Wang G, et al. A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B. Clin Chem. 2019;65(12):1543–53.PubMedCrossRef
4.
5.
go back to reference Allemani C, Matsuda T, Carlo VD, et al. Global surveillance of trends in cancer survival: analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers during 2000–2014 from 322 population-based registries in 71 countries (CONCORD-3). The Lancet. 2018;391(10125):1023–75.CrossRef Allemani C, Matsuda T, Carlo VD, et al. Global surveillance of trends in cancer survival: analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers during 2000–2014 from 322 population-based registries in 71 countries (CONCORD-3). The Lancet. 2018;391(10125):1023–75.CrossRef
6.
go back to reference Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018;101:72–81.PubMedCrossRef Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018;101:72–81.PubMedCrossRef
7.
go back to reference Vietti Violi N, Lewis S, Hectors S, et al. Radiological diagnosis and characterization of HCC. Hepatocellular Carcinoma. 2019;71–92. Vietti Violi N, Lewis S, Hectors S, et al. Radiological diagnosis and characterization of HCC. Hepatocellular Carcinoma. 2019;71–92.
8.
go back to reference Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2016;34(2):153–9.PubMedCrossRef Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2016;34(2):153–9.PubMedCrossRef
9.
10.
go back to reference Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–6.PubMedPubMedCentralCrossRef Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–6.PubMedPubMedCentralCrossRef
11.
go back to reference Tang A, Bashir MR, Corwin MT, et al. Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiol. 2018;286(1):29–48.CrossRef Tang A, Bashir MR, Corwin MT, et al. Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiol. 2018;286(1):29–48.CrossRef
12.
go back to reference Wu M, Tan H, Gao F, et al. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature. Eur Radiol. 2019;29(6):2802–11.PubMedCrossRef Wu M, Tan H, Gao F, et al. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature. Eur Radiol. 2019;29(6):2802–11.PubMedCrossRef
13.
go back to reference Zhou W, Zhang L, Wang K, et al. Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging Jmri. 2017;45(5):1476–84.PubMedCrossRef Zhou W, Zhang L, Wang K, et al. Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging Jmri. 2017;45(5):1476–84.PubMedCrossRef
14.
go back to reference Hectors SJ, Wagner M, Bane O, et al. Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging. Sci Rep. 2017;7(1):2452.PubMedPubMedCentralCrossRef Hectors SJ, Wagner M, Bane O, et al. Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging. Sci Rep. 2017;7(1):2452.PubMedPubMedCentralCrossRef
15.
go back to reference Zhou Y, He L, Huang Y, et al. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol. 2017;42(6):1695–704.CrossRef Zhou Y, He L, Huang Y, et al. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol. 2017;42(6):1695–704.CrossRef
16.
go back to reference Yang L, Gu D, Wei J, et al. A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Liver Cancer. 2019;8(5):373–86.PubMedCrossRef Yang L, Gu D, Wei J, et al. A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Liver Cancer. 2019;8(5):373–86.PubMedCrossRef
17.
go back to reference Huang X, Long L, Wei J, et al. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol. 2019;145(12):2995–3003.PubMedPubMedCentralCrossRef Huang X, Long L, Wei J, et al. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol. 2019;145(12):2995–3003.PubMedPubMedCentralCrossRef
18.
go back to reference Klein S, Staring M, Murphy K, Viergever MA, Pluim J. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29(1):196–205.PubMedCrossRef Klein S, Staring M, Murphy K, Viergever MA, Pluim J. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29(1):196–205.PubMedCrossRef
19.
go back to reference Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30(9):1323–41.PubMedPubMedCentralCrossRef Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30(9):1323–41.PubMedPubMedCentralCrossRef
20.
go back to reference van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Can Res. 2017;77(21):e104–7.CrossRef van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Can Res. 2017;77(21):e104–7.CrossRef
21.
go back to reference Hu Y, Xie C, Yang H, et al. Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA network open. 2020;3(9):e2015927.PubMedPubMedCentralCrossRef Hu Y, Xie C, Yang H, et al. Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA network open. 2020;3(9):e2015927.PubMedPubMedCentralCrossRef
22.
go back to reference Zhu WS, Shi SY, Yang ZH, Song C, Shen J. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure. World J Gastroenterol. 2020;26(11):1208–20.PubMedPubMedCentralCrossRef Zhu WS, Shi SY, Yang ZH, Song C, Shen J. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure. World J Gastroenterol. 2020;26(11):1208–20.PubMedPubMedCentralCrossRef
23.
go back to reference Wang JC, Fu R, Tao XW, et al. A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data. Biomark Res. 2020;8:47.PubMedPubMedCentralCrossRef Wang JC, Fu R, Tao XW, et al. A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data. Biomark Res. 2020;8:47.PubMedPubMedCentralCrossRef
24.
go back to reference Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036.PubMedPubMedCentral Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036.PubMedPubMedCentral
25.
go back to reference Zhu ZX, Huang JW, Liao MH, Zeng Y. Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection. Jpn J Clin Oncol. 2016;46(12):1075–80.PubMed Zhu ZX, Huang JW, Liao MH, Zeng Y. Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection. Jpn J Clin Oncol. 2016;46(12):1075–80.PubMed
26.
go back to reference De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis. 2018;50(11):1115–23.PubMedCrossRef De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis. 2018;50(11):1115–23.PubMedCrossRef
27.
28.
go back to reference Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol. 2009;44(Suppl 19):112–8.PubMedCrossRef Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol. 2009;44(Suppl 19):112–8.PubMedCrossRef
29.
go back to reference Kitao A, Zen Y, Matsui O, Toshifumi Gabata A, Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography–radiologic-pathologic correlation. Radiol. 2009;252(2):605–14.CrossRef Kitao A, Zen Y, Matsui O, Toshifumi Gabata A, Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography–radiologic-pathologic correlation. Radiol. 2009;252(2):605–14.CrossRef
30.
go back to reference Lee M, Kim K, Kim SY, et al. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma. Hum Pathol. 2018;81:37–46.PubMedCrossRef Lee M, Kim K, Kim SY, et al. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma. Hum Pathol. 2018;81:37–46.PubMedCrossRef
31.
go back to reference Quaia E, De Paoli L, Pizzolato R, et al. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase. AJR Am J Roentgenol. 2013;200(3):553–62.PubMedCrossRef Quaia E, De Paoli L, Pizzolato R, et al. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase. AJR Am J Roentgenol. 2013;200(3):553–62.PubMedCrossRef
32.
go back to reference Castelli G, Pelosi E, Testa U. Liver cancer: molecular characterization, clonal evolution and cancer stem cells. Cancers. 2017;9(9):127.PubMedCentralCrossRef Castelli G, Pelosi E, Testa U. Liver cancer: molecular characterization, clonal evolution and cancer stem cells. Cancers. 2017;9(9):127.PubMedCentralCrossRef
33.
go back to reference Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis. 2002;6(2):497–512.PubMedCrossRef Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis. 2002;6(2):497–512.PubMedCrossRef
34.
go back to reference Chou CT, Chou JM, Chang TA, et al. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol. 2013;19(42):7433–9.PubMedPubMedCentralCrossRef Chou CT, Chou JM, Chang TA, et al. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol. 2013;19(42):7433–9.PubMedPubMedCentralCrossRef
35.
go back to reference Kahng YS, Lee YS, Kim BK, Park WS, Lee JY, Kang CS. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18(4):430–6.PubMedCrossRef Kahng YS, Lee YS, Kim BK, Park WS, Lee JY, Kang CS. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18(4):430–6.PubMedCrossRef
36.
go back to reference Okada M, Imai Y, Kim T, et al. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010;32(4):903–13.PubMedCrossRef Okada M, Imai Y, Kim T, et al. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010;32(4):903–13.PubMedCrossRef
37.
go back to reference Kudo M. The 2008 Okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy. J Gastroenterol Hepatol. 2010;25(3):439–52.PubMedCrossRef Kudo M. The 2008 Okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy. J Gastroenterol Hepatol. 2010;25(3):439–52.PubMedCrossRef
38.
go back to reference Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol. 2007;17(11):2969–82.PubMedCrossRef Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol. 2007;17(11):2969–82.PubMedCrossRef
39.
go back to reference Hong HS, Hua SK, Kim MJ, Becker JD, Mitchell DG, Kanematsu M. Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique. J Magn Reson Imaging. 2008;28(2):396–402.PubMedCrossRef Hong HS, Hua SK, Kim MJ, Becker JD, Mitchell DG, Kanematsu M. Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique. J Magn Reson Imaging. 2008;28(2):396–402.PubMedCrossRef
40.
go back to reference Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol. 2011;197(5):868–75.CrossRef Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol. 2011;197(5):868–75.CrossRef
41.
go back to reference Kogita S, Imai Y, Okada M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol. 2010;20(10):2405–13.PubMedCrossRef Kogita S, Imai Y, Okada M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol. 2010;20(10):2405–13.PubMedCrossRef
42.
go back to reference Liu F, Liu D, Wang K, et al. Deep learning radiomics based on contrast-enhanced ultrasound might optimize curative treatments for very-early or early-stage hepatocellular carcinoma patients. Liver Cancer. 2020;9(4):397–413.PubMedPubMedCentralCrossRef Liu F, Liu D, Wang K, et al. Deep learning radiomics based on contrast-enhanced ultrasound might optimize curative treatments for very-early or early-stage hepatocellular carcinoma patients. Liver Cancer. 2020;9(4):397–413.PubMedPubMedCentralCrossRef
43.
go back to reference Ning P, Gao F, Hai J, et al. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol. 2020;45(1):64–72.CrossRef Ning P, Gao F, Hai J, et al. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol. 2020;45(1):64–72.CrossRef
44.
go back to reference Yuan C, Wang Z, Gu D, et al. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram. Cancer Imaging : Off Publ Int Cancer Imaging Soc. 2019;19(1):21.CrossRef Yuan C, Wang Z, Gu D, et al. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram. Cancer Imaging : Off Publ Int Cancer Imaging Soc. 2019;19(1):21.CrossRef
45.
go back to reference Zhao Y, Wu J, Zhang Q, et al. Radiomics analysis based on multiparametric mri for predicting early recurrence in hepatocellular carcinoma after partial hepatectomy. J magn reson imaging : JMRI. 2021;53(4):1066–79.PubMedCrossRef Zhao Y, Wu J, Zhang Q, et al. Radiomics analysis based on multiparametric mri for predicting early recurrence in hepatocellular carcinoma after partial hepatectomy. J magn reson imaging : JMRI. 2021;53(4):1066–79.PubMedCrossRef
46.
go back to reference Shan QY, Hu HT, Feng ST, et al. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation. Cancer imaging : Off Publ Int Cancer Imaging Soc. 2019;19(1):11.CrossRef Shan QY, Hu HT, Feng ST, et al. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation. Cancer imaging : Off Publ Int Cancer Imaging Soc. 2019;19(1):11.CrossRef
47.
go back to reference Kim S, Shin J, Kim D-Y, Choi GH, Kim M-J, Choi J-Y. Radiomics on gadoxetic acid–enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res. 2019;25(13):3847–55.PubMedCrossRef Kim S, Shin J, Kim D-Y, Choi GH, Kim M-J, Choi J-Y. Radiomics on gadoxetic acid–enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res. 2019;25(13):3847–55.PubMedCrossRef
48.
go back to reference Zhang Z, Jiang H, Chen J, et al. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer imaging : Off Publ Int Cancer Imaging Soc. 2019;19(1):22.CrossRef Zhang Z, Jiang H, Chen J, et al. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer imaging : Off Publ Int Cancer Imaging Soc. 2019;19(1):22.CrossRef
49.
go back to reference Guo D, Gu D, Wang H, et al. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation. Eur J Radiol. 2019;117:33–40.PubMedCrossRef Guo D, Gu D, Wang H, et al. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation. Eur J Radiol. 2019;117:33–40.PubMedCrossRef
50.
go back to reference Wu J, Liu A, Cui J, Chen A, Xie L. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging. 2019;19(1):23.PubMedPubMedCentralCrossRef Wu J, Liu A, Cui J, Chen A, Xie L. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging. 2019;19(1):23.PubMedPubMedCentralCrossRef
51.
go back to reference Wang W, Gu D, Wei J, et al. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid–enhanced MRI. Eur Radiol. 2020;30(5):3004–14.PubMedCrossRef Wang W, Gu D, Wei J, et al. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid–enhanced MRI. Eur Radiol. 2020;30(5):3004–14.PubMedCrossRef
52.
go back to reference Jiang YQ, Cao SE, Cao S, et al. Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning. J Cancer Res Clin Oncol. 2021;147(3):821–33.PubMedCrossRef Jiang YQ, Cao SE, Cao S, et al. Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning. J Cancer Res Clin Oncol. 2021;147(3):821–33.PubMedCrossRef
53.
go back to reference Brinkmann G, Melchert UH, Lalk G, et al. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases. Invest Radiol. 1997;32(2):100–4.PubMedCrossRef Brinkmann G, Melchert UH, Lalk G, et al. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases. Invest Radiol. 1997;32(2):100–4.PubMedCrossRef
Metadata
Title
Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions
Authors
Kui Sun
Liting Shi
Jianfeng Qiu
Yuteng Pan
Ximing Wang
Haiyan Wang
Publication date
01-03-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05742-8

Other articles of this Issue 8/2022

European Journal of Nuclear Medicine and Molecular Imaging 8/2022 Go to the issue